BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 1063-1069

  Braaten, Kristina M ^a   Betensky, Rebecca A ^b   De Leval, Laurence ^a   Okada, Yoshifumi ^a   Hochberg, Fred H ^a   Louis, David N ^a   Harris, Nancy L ^a   Batchelor, Tracy T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; METHOTREXATE; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN P16; PROTEIN P53; SYNDECAN 1;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DISEASE MARKER; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENERAL HOSPITAL; HISTOGENESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLAST; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MORPHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTIGENS, CD44; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON REGULATORY FACTORS; LYMPHOMA; MALE; MEMBRANE GLYCOPROTEINS; METHOTREXATE; MIDDLE AGED; NEPRILYSIN; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; SYNDECAN-1; SYNDECANS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037341470     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Central Brain Tumor Registry of the United States: 1997 Annual Report. Central Brain Tumor Registry of the United States, Chicago, IL, 1998.
2. Maher, E. A., and Fine, H. A. Primary CNS lymphoma. Semin. Oncol., 26: 346-356, 1999.
3. Cote, T. R., Manns, A., Hardy, C. R., Yellin, F. J., Hartge, P., and the AIDS/Cancer Study Group. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J. Natl. Cancer Inst. (Bethesda), 88: 675-679, 1996.
4. Larocca, L. M., Capello, D., Rinelli, A., Nori, S., Antinori, A., Gloghini, A., Cingolani, A., Migliazza, A., Saglio, G., Cammilleri-Broet, S., Raphael, M., Carbone, A., and Gaidano, G. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood, 92: 1011-1019, 1998.
5. Thompsett, A. R., Ellison, D. W., Stevenson, F. K., and Zhu, D. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood, 94: 1738-1746, 1999.
6. Plotkin, S. R., and Batchelor, T. T. Primary nervous-system lymphoma. Lancet Oncol., 2: 354-365, 2001.
7. Jaffe, E. S., Harris, N. L., Vardiman, J. W., and Stein, H. Pathology and genetics: neoplasms of the hematopoietic and lymphoid tissues. In: P. Kleihues and L. Sobin (eds), World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2002.
8. Lennert, K., and Feller, A. Histopathology of Non-Hodgkin's Lymphomas, 2nd ed. New York: Springer-Verlag, 1992.
9. Burns, K., Ueki, K., Jhung, S. L., Koh, J., and Louis, D. N. Molecular genetic correlates of p16, cdk4 and pRb immunohistochemistry in glioblastomas. J. Neuropathol. Exp. Neurol., 57: 122-130, 1998.
10. Dreyling, M. H., Bohlander, S. K., Adeyanju, M. O., and Olopade, O. I. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res., 55: 984-988, 1995.
11. Ono, Y., Tamiya, T., Ichikawa, T., Kunishio, K., Matsumoto, K., Furuta, T., Ohmoto, T., Ueki, K., and Louis, D. N. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J. Neuropathol. Exp. Neurol., 55: 1026-1031, 1996.
12. Chang, C. C., Ye, B. H., Chaganti, R. S. K., and Dalla-Favera, R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA, 93: 6947-6952, 1996.
13. Dent, A. L., Shaffer, A. L., Yu, X., Allman, D., and Staudt, L. M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science (Wash. DC), 276: 589-592, 1997.
14. Falini, B., Fizzotti, M., Liso, A., Pasqualucci, L., and Flenghi, L. Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Ann. Oncol., 8 (Suppl. 2): S101-S104, 1997.
15. Dogan, A., Bagdi, E., Munson, P., and Isaacson, P. G. CD10 and BCL6 expression in paraffin sections of normal lymphoid tissue and B-cell neoplasms. Am. J. Surg. Pathol., 24: 846-852, 2000.
16. Gaidano, G., and Carbone, A. MUMI: a step ahead toward the understanding of lymphoma histogenesis. Leukemia (Baltimore), 14: 563-566, 2000.
17. Turley, H., Jones, M., Erber, W., Mayne, K., de Waele, M., and Gatter, K. VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. J. Clin. Pathol., 47: 418-422, 1994.
18. Kremmidiotis, G., Ridings, J., Hicks, M., Beckman, I. G. R., Bryson, G., Collins, R., and Zola, H. Heterogeneity of CD44 expression among human B-cell subpopulations. Tissue Antigens, 51: 232-241, 1998.
19. Eshoa, C., Perkins, S., Bunyi-Teopengco, E., Schultz, G., Kampalath, B., Chivukula, M., and Chang, C, Expression of p53 and EBV-LMP correlates with survival in primary central nervous system diffuse large B-cell lymphoma. Mod. Pathol., 14: 162A, 2001.
20. Au, W. Y., Chan, A. C., Srivastava, G., Leung, S. Y., and Liang, R. Incidence and pathology of primary brain lymphomas in Hong Kong Chinese patients. Leuk. Lymphoma, 37: 175-179, 2000.
21. Corry, J., Smith, J. G., Wirth, A., Quong, G., and Liew, K. H. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int. J. Radiat. Oncol. Biol. Phys., 41: 615-620, 1998.
22. Blay, J. Y., Conroy, T., Chevreau, C., Thyss, A., Quesnel, N., Eghbali, H., Bouabdallah, R., Coiffier, B., Wagner, J. P., Le Mevel, A., Dramais-Marcel, D., Baumelou, E., Chauvin, F., and Biron, P. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J. Clin. Oncol., 16: 864-871, 1998.
23. Lagakos, S. W., and Schoenfeld, D. A. Properties of proportionalhazards score tests under misspecified regression models. Biometrics, 40: 1037-1048, 1984.
24. Engelhard, M., Brittinger, G., Huhn, D., Gerhartz, H. H., Meusers, P., Siegert, W., Thiel, E., Wilmanns, W., Aydemir, U., Bierwolf, S., Griesser, H., Tiemann, M., and Lenner, K. Subclassification of diffuse large B-cell lymphomas according to the Kiel Classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood, 89: 2291-2297, 1997.
25. Baars, J. W., de Jong, D., Willemse, E. M., Gras, L., Dalesio, O., v. Heerde, P., Huygens, P. C., v. d. Lelie, H., and Kr v. d. Borne, A. E. G. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification. Br. J. Cancer, 79: 1770-1776, 1999.
26. Camilleri-Broet, S., Martin, A., Moreau, A., Angonin, R., Henin, D., Gontier, M. F., Rousselet, M. C., Caulet-Maugendre, S., Cuillierre, P., Lefrancq, T., Mokhtari, K., Morcos, M., Broet, P., Kujas, M., Hauw, J. J., Desablens, B., and Raphael, M. Primary central nervous system lymphomas in 72 immunocompetent patients. Am. J. Clin. Pathol., 110: 607-612, 1998.
27. Goscoyne, R. D., Adomat, S. A., Krajewski, S., Krajewska, M., Horsman, D. E., Tolcher, A. W., O'Reilly, S. E., Hoskins, P., Coldman, A. J., Reed, J. C., and Connors, J. M. Prognostic significance of Bcl-2 protein expression and BCL-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood, 90: 244-251, 1997.
28. Sherr, C. J. Cancer cell cycles. Science (Wash. DC), 274: 1672-1677, 1996.
29. Cobbers, J. M., Wolter, M., Reifenberger, J., Ring, G. U., Jessen, F., An, H. X., Niederacher, D., Schmidt, E. E., Ichimura, K., Floeth, F., Kirsch, L., Borchard, F., Louis, D. N., Collins, V. P., and Reifenberger, G. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL, Brain Pathol., 8: 263-276, 1998.
30. INK4a genes in primary central nervous system lymphomas. Cancer Res., 61: 6335-6339, 2001.
31. INK4A. Leukemia (Baltimore), 14: 898-904, 2000.
32. INK4b expression in normal human adult and infant tissues. Lab. Investig., 79: 1137-1145, 1999.
33. Villuendas, R., Sanchez-Beato, M., Martinez, J. C., Saez, A. I., Martinez-Delgado, B., Garcia, J. F., Sol Mateo, M., Sanchez-Verde, L., Benitez, J., Martinez, P., and Piris, M. A. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am. J. Pathol., 153: 887-897, 1998.
34. INK4B characterize the major types of hematological malignancies. Cancer Res., 57: 837-841, 1997.
35. Martinez-Delgado, B., Richart, A., Garcia, M. J., Robledo, M., Osorio, A., Cebrian, A., Rivas, C., and Benitez, J., Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas. Br. J. Haematol., 109: 97-103, 2000.
36. Capello, D., and Gaidano, G. Molecular pathophysiology of indolent lymphoma. Haematologica, 85: 195-201, 2000.
37. Nozaki, M., Tada, M., Matsumoto, R., Sawamura, Y., Abe, H., and Iggo, R. D. Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the CNS: reappraisal by yeast functional assay. Acta Neuropathol., 95: 291-296, 1998.
38. Lossos, I. S., Jones, C. D., Natkunam, Y., Kaizer, H., Zehnder, J. L., Tibshirani, R., and Levy, R. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood, 98: 945-951, 2001.
39. Takeshita, M., Iwashita, A., Kurihara, K., Ikejiri, J., Higashi, H., Udoh, T., and Kikuchi, M. Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma. Am. J. Surg. Pathol., 24: 1641-1669, 2000.